314 related articles for article (PubMed ID: 11717336)
21. Cytosine methylation represses glutathione S-transferase P1 (GSTP1) gene expression in human prostate cancer cells.
Singal R; van Wert J; Bashambu M
Cancer Res; 2001 Jun; 61(12):4820-6. PubMed ID: 11406558
[TBL] [Abstract][Full Text] [Related]
22. Impact of hormonal therapy on the detection of promoter hypermethylation of the detoxifying glutathione-S-transferase P1 gene (GSTP1) in prostate cancer.
Kollermann J; Kempkensteffen C; Helpap B; Schrader M; Krause H; Muller M; Miller K; Schostak M
BMC Urol; 2006 Jun; 6():15. PubMed ID: 16803634
[TBL] [Abstract][Full Text] [Related]
23. Reversal of GSTP1 CpG island hypermethylation and reactivation of pi-class glutathione S-transferase (GSTP1) expression in human prostate cancer cells by treatment with procainamide.
Lin X; Asgari K; Putzi MJ; Gage WR; Yu X; Cornblatt BS; Kumar A; Piantadosi S; DeWeese TL; De Marzo AM; Nelson WG
Cancer Res; 2001 Dec; 61(24):8611-6. PubMed ID: 11751372
[TBL] [Abstract][Full Text] [Related]
24. Glutathione S-transferase pi (GSTP1) hypermethylation in prostate cancer: review 2007.
Meiers I; Shanks JH; Bostwick DG
Pathology; 2007 Jun; 39(3):299-304. PubMed ID: 17558856
[TBL] [Abstract][Full Text] [Related]
25. Hypermethylation of the CpG islands in the promoter region of the GSTP1 gene in prostate cancer: a useful diagnostic and prognostic marker?
Bernardini S; Miano R; Iori R; Finazzi-Agrò E; Palmieri G; Ballerini S; Angeloni C; Orlandi A; Bellincampi L; Cortese C; Federici G
Clin Chim Acta; 2004 Dec; 350(1-2):181-8. PubMed ID: 15530476
[TBL] [Abstract][Full Text] [Related]
26. Preneoplastic prostate lesions: an opportunity for prostate cancer prevention.
Nelson WG; De Marzo AM; Deweese TL; Lin X; Brooks JD; Putzi MJ; Nelson CP; Groopman JD; Kensler TW
Ann N Y Acad Sci; 2001 Dec; 952():135-44. PubMed ID: 11795433
[TBL] [Abstract][Full Text] [Related]
27. Methylation of multiple genes in prostate cancer and the relationship with clinicopathological features of disease.
Singal R; Ferdinand L; Reis IM; Schlesselman JJ
Oncol Rep; 2004 Sep; 12(3):631-7. PubMed ID: 15289848
[TBL] [Abstract][Full Text] [Related]
28. Molecular Diagnostic of Prostate Cancer From Body Fluids Using Methylation-Specific PCR (MS-PCR) Method.
Minciu R; Dumache R; Gheorghe P; Daminescu L; Rogobete AF; Ionescu D
Clin Lab; 2016; 62(6):1183-6. PubMed ID: 27468582
[TBL] [Abstract][Full Text] [Related]
29. DNA-based detection of prostate cancer in urine after prostatic massage.
Goessl C; Müller M; Heicappell R; Krause H; Straub B; Schrader M; Miller K
Urology; 2001 Sep; 58(3):335-8. PubMed ID: 11549474
[TBL] [Abstract][Full Text] [Related]
30. A quantitative promoter methylation profile of prostate cancer.
Jerónimo C; Henrique R; Hoque MO; Mambo E; Ribeiro FR; Varzim G; Oliveira J; Teixeira MR; Lopes C; Sidransky D
Clin Cancer Res; 2004 Dec; 10(24):8472-8. PubMed ID: 15623627
[TBL] [Abstract][Full Text] [Related]
31. Preoperative serum DNA GSTP1 CpG island hypermethylation and the risk of early prostate-specific antigen recurrence following radical prostatectomy.
Bastian PJ; Palapattu GS; Lin X; Yegnasubramanian S; Mangold LA; Trock B; Eisenberger MA; Partin AW; Nelson WG
Clin Cancer Res; 2005 Jun; 11(11):4037-43. PubMed ID: 15930338
[TBL] [Abstract][Full Text] [Related]
32. GSTA1 expression in normal, preneoplastic, and neoplastic human prostate tissue.
Parsons JK; Nelson CP; Gage WR; Nelson WG; Kensler TW; De Marzo AM
Prostate; 2001 Sep; 49(1):30-7. PubMed ID: 11550208
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic and prognostic information in prostate cancer with the help of a small set of hypermethylated gene loci.
Bastian PJ; Ellinger J; Wellmann A; Wernert N; Heukamp LC; Müller SC; von Ruecker A
Clin Cancer Res; 2005 Jun; 11(11):4097-106. PubMed ID: 15930345
[TBL] [Abstract][Full Text] [Related]
34. Comparison of telomerase activity and GSTP1 promoter methylation in ejaculate as potential screening tests for prostate cancer.
Suh CI; Shanafelt T; May DJ; Shroyer KR; Bobak JB; Crawford ED; Miller GJ; Markham N; Glode LM
Mol Cell Probes; 2000 Aug; 14(4):211-7. PubMed ID: 10970725
[TBL] [Abstract][Full Text] [Related]
35. Prospective diagnostic efficiency of biopsy washing DNA GSTP1 island hypermethylation for detection of adenocarcinoma of the prostate.
Eilers T; Machtens S; Tezval H; Blaue C; Lichtinghagen R; Hagemann J; Jonas U; Serth J
Prostate; 2007 May; 67(7):757-63. PubMed ID: 17373715
[TBL] [Abstract][Full Text] [Related]
36. Polymorphisms of GSTP1 and related genes and prostate cancer risk.
Beer TM; Evans AJ; Hough KM; Lowe BA; McWilliams JE; Henner WD
Prostate Cancer Prostatic Dis; 2002; 5(1):22-7. PubMed ID: 15195126
[TBL] [Abstract][Full Text] [Related]
37. Progressive Spreading of DNA Methylation in the GSTP1 Promoter CpG Island across Transitions from Precursors to Invasive Prostate Cancer.
Gupta H; Inoue H; Nakai Y; Nakayama M; Jones T; Hicks JL; Kumar B; Gurel M; Nelson WG; De Marzo AM; Yegnasubramanian S
Cancer Prev Res (Phila); 2023 Aug; 16(8):449-460. PubMed ID: 37347938
[TBL] [Abstract][Full Text] [Related]
38. Promoter methylation profile of GSTP1 and RASSF1A in prostate cancerand benign hyperplasia in Vietnamese men.
Vo TT; Ta BT; Ta VT; Vuong DL; Nguyen QU
Turk J Med Sci; 2016 Jan; 46(1):228-35. PubMed ID: 27511358
[TBL] [Abstract][Full Text] [Related]
39. GSTP1 promoter methylation is associated with recurrence in early stage prostate cancer.
Maldonado L; Brait M; Loyo M; Sullenberger L; Wang K; Peskoe SB; Rosenbaum E; Howard R; Toubaji A; Albadine R; Netto GJ; Hoque MO; Platz EA; Sidransky D
J Urol; 2014 Nov; 192(5):1542-8. PubMed ID: 24769028
[TBL] [Abstract][Full Text] [Related]
40. Methylation-specific PCR for DNA-based detection of occult tumor cells in lymph nodes of prostate cancer patients.
Köllermann J; Müller M; Goessl C; Krause H; Helpap B; Pantel K; Miller K
Eur Urol; 2003 Nov; 44(5):533-8. PubMed ID: 14572750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
